Congrats! Zenshine Pharmaceuticals announced that Project ZX-7101A got approval from NMPA for Clinical Trial!
Nanjing Zenshine Pharmaceuticals Co , Ltd (Zenshine) announced that NMPA has approved their IND application of ZX-7101A to progress a phase 1 clinical study for the treatment of Influenza virus infection